Vischer advised Relief, now MindMaze Therapeutics Holding, in connection with its acquisition of all shares in NeuroX Group, against issuance of new MMTX shares to complete their business combination by way of reverse merger.
Vischer advised Relief, now MindMaze Therapeutics Holding, in connection with its acquisition of all shares in NeuroX Group, against issuance of new MMTX shares to complete their business combination by way of reverse merger.